Cargando…
Use of Antioxidants for the Neuro-Therapeutic Management of COVID-19
Coronavirus Disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), is an emergent infectious disease that has caused millions of deaths throughout the world. COVID-19 infection’s main symptoms are fever, cough, fatigue, and neurological manifestations such a...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235474/ https://www.ncbi.nlm.nih.gov/pubmed/34204362 http://dx.doi.org/10.3390/antiox10060971 |
_version_ | 1783714326978232320 |
---|---|
author | Cárdenas-Rodríguez, Noemí Bandala, Cindy Vanoye-Carlo, América Ignacio-Mejía, Iván Gómez-Manzo, Saúl Hernández-Cruz, Estefani Yaquelin Pedraza-Chaverri, José Carmona-Aparicio, Liliana Hernández-Ochoa, Beatriz |
author_facet | Cárdenas-Rodríguez, Noemí Bandala, Cindy Vanoye-Carlo, América Ignacio-Mejía, Iván Gómez-Manzo, Saúl Hernández-Cruz, Estefani Yaquelin Pedraza-Chaverri, José Carmona-Aparicio, Liliana Hernández-Ochoa, Beatriz |
author_sort | Cárdenas-Rodríguez, Noemí |
collection | PubMed |
description | Coronavirus Disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), is an emergent infectious disease that has caused millions of deaths throughout the world. COVID-19 infection’s main symptoms are fever, cough, fatigue, and neurological manifestations such as headache, myalgias, anosmia, ageusia, impaired consciousness, seizures, and even neuromuscular junctions’ disorders. In addition, it is known that this disease causes a series of systemic complications such as adverse respiratory distress syndrome, cardiac injury, acute kidney injury, and liver dysfunction. Due to the neurological symptoms associated with COVID-19, damage in the central nervous system has been suggested as well as the neuroinvasive potential of SARS-CoV-2. It is known that CoV infections are associated with an inflammation process related to the imbalance of the antioxidant system; cellular changes caused by oxidative stress contribute to brain tissue damage. Although anti-COVID-19 vaccines are under development, there is no specific treatment for COVID-19 and its clinical manifestations and complications; only supportive treatments with immunomodulators, anti-vascular endothelial growth factors, modulating drugs, statins, or nutritional supplements have been used. In the present work, we analyzed the potential of antioxidants as adjuvants for the treatment of COVID-19 and specifically their possible role in preventing or decreasing the neurological manifestations and neurological complications present in the disease. |
format | Online Article Text |
id | pubmed-8235474 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-82354742021-06-27 Use of Antioxidants for the Neuro-Therapeutic Management of COVID-19 Cárdenas-Rodríguez, Noemí Bandala, Cindy Vanoye-Carlo, América Ignacio-Mejía, Iván Gómez-Manzo, Saúl Hernández-Cruz, Estefani Yaquelin Pedraza-Chaverri, José Carmona-Aparicio, Liliana Hernández-Ochoa, Beatriz Antioxidants (Basel) Review Coronavirus Disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), is an emergent infectious disease that has caused millions of deaths throughout the world. COVID-19 infection’s main symptoms are fever, cough, fatigue, and neurological manifestations such as headache, myalgias, anosmia, ageusia, impaired consciousness, seizures, and even neuromuscular junctions’ disorders. In addition, it is known that this disease causes a series of systemic complications such as adverse respiratory distress syndrome, cardiac injury, acute kidney injury, and liver dysfunction. Due to the neurological symptoms associated with COVID-19, damage in the central nervous system has been suggested as well as the neuroinvasive potential of SARS-CoV-2. It is known that CoV infections are associated with an inflammation process related to the imbalance of the antioxidant system; cellular changes caused by oxidative stress contribute to brain tissue damage. Although anti-COVID-19 vaccines are under development, there is no specific treatment for COVID-19 and its clinical manifestations and complications; only supportive treatments with immunomodulators, anti-vascular endothelial growth factors, modulating drugs, statins, or nutritional supplements have been used. In the present work, we analyzed the potential of antioxidants as adjuvants for the treatment of COVID-19 and specifically their possible role in preventing or decreasing the neurological manifestations and neurological complications present in the disease. MDPI 2021-06-17 /pmc/articles/PMC8235474/ /pubmed/34204362 http://dx.doi.org/10.3390/antiox10060971 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Cárdenas-Rodríguez, Noemí Bandala, Cindy Vanoye-Carlo, América Ignacio-Mejía, Iván Gómez-Manzo, Saúl Hernández-Cruz, Estefani Yaquelin Pedraza-Chaverri, José Carmona-Aparicio, Liliana Hernández-Ochoa, Beatriz Use of Antioxidants for the Neuro-Therapeutic Management of COVID-19 |
title | Use of Antioxidants for the Neuro-Therapeutic Management of COVID-19 |
title_full | Use of Antioxidants for the Neuro-Therapeutic Management of COVID-19 |
title_fullStr | Use of Antioxidants for the Neuro-Therapeutic Management of COVID-19 |
title_full_unstemmed | Use of Antioxidants for the Neuro-Therapeutic Management of COVID-19 |
title_short | Use of Antioxidants for the Neuro-Therapeutic Management of COVID-19 |
title_sort | use of antioxidants for the neuro-therapeutic management of covid-19 |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235474/ https://www.ncbi.nlm.nih.gov/pubmed/34204362 http://dx.doi.org/10.3390/antiox10060971 |
work_keys_str_mv | AT cardenasrodrigueznoemi useofantioxidantsfortheneurotherapeuticmanagementofcovid19 AT bandalacindy useofantioxidantsfortheneurotherapeuticmanagementofcovid19 AT vanoyecarloamerica useofantioxidantsfortheneurotherapeuticmanagementofcovid19 AT ignaciomejiaivan useofantioxidantsfortheneurotherapeuticmanagementofcovid19 AT gomezmanzosaul useofantioxidantsfortheneurotherapeuticmanagementofcovid19 AT hernandezcruzestefaniyaquelin useofantioxidantsfortheneurotherapeuticmanagementofcovid19 AT pedrazachaverrijose useofantioxidantsfortheneurotherapeuticmanagementofcovid19 AT carmonaaparicioliliana useofantioxidantsfortheneurotherapeuticmanagementofcovid19 AT hernandezochoabeatriz useofantioxidantsfortheneurotherapeuticmanagementofcovid19 |